B

BiVACOR

Develops magnetically levitated total artificial heart

Manufacturing Technician

Product AssemblyConfirmed live in the last 24 hours
Full-timeHuntington Beach, CA, USAIn-person

About the Job

Requirements

  • Four to seven years of experience in electrical assembly, wire harnessing, or electromechanical manufacturing.
  • Strong experience with wiring, cable harnessing, soldering small-gauge wires, and printed circuit board work.
  • Ability to read and interpret schematics and detailed technical documentation.
  • Ability to work independently with a quality-first mindset.
  • Strong attention to detail and documentation discipline.

Responsibilities

  • Perform precision wiring, cable harnessing, crimping, and fine soldering of electrical assemblies.
  • Assist with printed circuit board assembly and electrical integration of control systems.
  • Conduct in-process electrical and functional testing using in-house test equipment.
  • Troubleshoot assembly and electrical issues and support root cause investigations.
  • Support prototype builds, design verification, and validation activities alongside engineers.
  • Set up and maintain assembly and test equipment, including basic calibration and preventive maintenance.
  • Complete accurate production documentation, including device history records in compliance with Good Manufacturing Practice and Food and Drug Administration standards.
  • Mentor junior operators and maintain compliance within a cleanroom, regulated manufacturing environment.

Desired Qualifications

  • Experience within regulated industries such as medical devices or aerospace.

About the Company

BiVACOR

Develops magnetically levitated total artificial heart

BiVACOR is a clinical-stage medical device company developing the BiVACOR Total Artificial Heart (TAH) to replace a failing heart. The device is a compact, titanium implant that uses a single magnetically levitated rotor to pump blood to the lungs and the rest of the body, eliminating valves and mechanical bearings to reduce blood damage. It serves as a bridge-to-transplant and aims to become a long-term (permanent) alternative to heart transplantation. BiVACOR operates in the cardiovascular medtech space, pursuing regulatory approval through preclinical and clinical trials, including an FDA Breakthrough Device Designation and an Early Feasibility Study. Its strategy includes expanding from Australia to the US, securing funding, and advancing toward commercialization to address the large unmet need in end-stage heart failure.

Company size
51-200
Company stage
Grant
Total funding
$46.7M
Headquarters
Huntington Beach, CA
Founded
2008

Recently Posted Jobs

Explore more opportunities at BiVACOR

See more jobs